Results 81 to 90 of about 1,386 (146)

A novel mutation in the ABCD1 gene of a Moroccan patient with X-linked adrenoleukodystrophy: case report [PDF]

open access: yes, 2015
International audienceAbstractBackgroundX-linked adrenoleukodystrophy (X-ALD; OMIM: 300100) is the most common peroxisomal disease caused by mutations in the ATP-binding cassette, sub-family D member 1 gene or ABCD1 (geneID: 215), the coding gene for the
Ilham Slassi   +15 more
core   +1 more source

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy [PDF]

open access: yes, 1997
X linked adrenoleukodystrophy (X-ALD) is an inherited disorder of peroxisomal metabolism, biochemically characterised by accumulation of saturated very long chain fatty acids.
B M Van Geel   +10 more
core   +1 more source

Disease progression in women with X-linked adrenoleukodystrophy is slow

open access: yesOrphanet Journal of Rare Diseases, 2019
Background Over 80% of women with X-linked adrenoleukodystrophy (ALD) develop spinal cord disease in adulthood for which treatment is supportive only. For future clinical trials quantitative data on disease progression rates are essential.
Irene C. Huffnagel   +7 more
doaj   +1 more source

Fulminant Adrenal Crisis as the Initial Healthcare System Presentation of Adolescent Cerebral X‐Linked Adrenoleukodystrophy

open access: yes
CNS Neuroscience &Therapeutics, Volume 32, Issue 4, April 2026.
Junqiu Zhou   +3 more
wiley   +1 more source

Progress report on the cost-effectiveness of X-linked adrenoleukodystrophy newborn screening [PDF]

open access: yes, 2017
This research was supported by the Undergraduate Research Opportunities Program (UROP).Parikh, Aditya; Miller, Weston. (2017). Progress report on the cost-effectiveness of X-linked adrenoleukodystrophy newborn screening.
Miller, Weston, Parikh, Aditya
core  

Lorenzo’s Oil in Treatment of Asymptomatic ALD

open access: yesPediatric Neurology Briefs, 2005
The effect of 4:1 glyceryl trioleate-glyceryl trierucate (Lorenzo’s oil) on disease progression in 89 asymptomatic boys (mean age 4.7+/-4.1 years; range 0.2-15 years) with X-linked adrenoleukodystrophy (ALD) and normal brain MRI was studied at Johns ...
J Gordon Millichap
doaj   +1 more source

Prenatal diagnosis of X‐linked adrenoleukodystrophy associated with isolated pericardial effusion [PDF]

open access: yes, 2015
This is the first reported case of fetal pericardial effusion in association with X-linked adrenoleukodystrophy and hypocortisolism from a nonautoimmune cause.
Di Tommaso, Mariarosaria   +13 more
core   +1 more source

Clinical, biochemical and genetic profiling of X-linked adrenoleukodystrophy in Egyptian pediatric patients: a hospital-based study

open access: yesEgyptian Journal of Medical Human Genetics
Background X-linked adrenoleukodystrophy, the most common peroxisomal disorder, is caused by ABCD1 gene mutations. This genetic disorder is characterized by the defective degradation of very long-chain fatty acids.
Dina A. Mehaney   +9 more
doaj   +1 more source

Central precocious puberty in a boy with X-linked adrenoleukodystrophy caused by a novel ABCD1 mutation

open access: yesHeliyon
X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder caused by pathogenic variants in the ABCD1 gene. The symptoms include primary adrenal insufficiency (PAI), progressive spinal cord disease, inflammatory demyelinating cerebral disease, and ...
Chaoyue Zhao   +5 more
doaj   +1 more source

X-linked adrenoleukodystrophy; Recent Advances in Classification, Diagnosis and Management

open access: yes, 2017
X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ATP binding cassette subfamily D member 1 (ABCD1), a gene that encodes peroxisomal membrane located on ABC half-transporter named adrenoleukodystrophy protein (ALDP).
고아라, 정을식, 강훈철
core  

Home - About - Disclaimer - Privacy